Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifevantage (LFVN) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Lifevantage (LFVN) over the last 15 years, with Q4 2025 value amounting to $5.5 million.

  • Lifevantage's Accumulated Expenses fell 3052.62% to $5.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $5.5 million, marking a year-over-year decrease of 3052.62%. This contributed to the annual value of $7.2 million for FY2025, which is 808.99% down from last year.
  • Lifevantage's Accumulated Expenses amounted to $5.5 million in Q4 2025, which was down 3052.62% from $6.0 million recorded in Q3 2025.
  • In the past 5 years, Lifevantage's Accumulated Expenses registered a high of $8.2 million during Q1 2025, and its lowest value of $5.5 million during Q4 2025.
  • Over the past 5 years, Lifevantage's median Accumulated Expenses value was $7.3 million (recorded in 2022), while the average stood at $7.2 million.
  • Over the last 5 years, Lifevantage's Accumulated Expenses had its largest YoY gain of 3417.04% in 2025, and its largest YoY loss of 3052.62% in 2025.
  • Lifevantage's Accumulated Expenses (Quarter) stood at $7.5 million in 2021, then fell by 10.95% to $6.7 million in 2022, then grew by 1.6% to $6.8 million in 2023, then grew by 16.86% to $7.9 million in 2024, then tumbled by 30.53% to $5.5 million in 2025.
  • Its Accumulated Expenses stands at $5.5 million for Q4 2025, versus $6.0 million for Q3 2025 and $7.2 million for Q2 2025.